Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…
Biotechnology
US, Stafford [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Greenwich LifeSciences, Inc. has no acquisition track records yet.
M&A Deals · History
Greenwich LifeSciences, Inc. has no acquisition track records yet.